Tooth Regeneration
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
96
NCT06003621
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 15, 2023
Completion: Nov 1, 2028
Loading map...